Disclosure 0001193125-26-377309-2

SEC FORM 4

$42,683.62

Xenon Pharmaceuticals Inc. (XENE)

Sale of 700 shares at $60.9766 per share.

Reporting Person KENNEY CHRISTOPHER JOHN · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 28, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001193125-26-377309 · filed 2026-08-31 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Xenon Pharmaceuticals Inc. (XENE)." Disclosed 2026-08-31. https://desqlong.com/cards/0001193125-26-377309-2 (retrieved 2026-09-26).